Company / Depreciation & Amortization
Editas Medicine, Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$5.8M
FY2025
5-year range
$2.8M / $6.3M
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 8 years, ranging from $1M in FY2018 to $6M in FY2024.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of +12.3%.
Increased from $5M to $6M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +12.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +12.3%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 8.3% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | -8.3% |
| FY2024 | $6.3M | +25.4% |
| FY2023 | $5.1M | +27.6% |
| FY2022 | $4.0M | +39.9% |
| FY2021 | $2.8M | -13.0% |
| FY2020 | $3.3M | +21.3% |
| FY2019 | $2.7M | +123.2% |
| FY2018 | $1.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026